Animal Therapeutics and Diagnostics Market Report 2026

The animal therapeutics and diagnostics market size has grown strongly in recent years. It will grow from $51.62 billion in 2025 to $54.9 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increasing prevalence of animal diseases, growth in livestock production, rising companion animal ownership, expansion of veterinary clinics and hospitals, availability of established veterinary drugs.

The animal therapeutics and diagnostics market size is expected to see strong growth in the next few years. It will grow to $72.41 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to growing demand for precision animal medicine, rising investment in veterinary diagnostics innovation, increasing focus on antimicrobial stewardship, expansion of point-of-care testing, growth in animal healthcare expenditure. Major trends in the forecast period include rising demand for integrated therapeutics and diagnostics, increasing focus on early disease detection in animals, growth in preventive animal healthcare practices, expanding use of combination drug therapies, rising adoption of in-clinic diagnostic testing.

The rising rate of pet adoption is expected to drive the growth of the animal therapeutics and diagnostics market going forward. A pet is a domesticated animal kept mainly for companionship, enjoyment, or personal interest rather than for utility purposes such as farming or research. While pets often develop strong emotional bonds with their owners, they may also serve secondary roles such as security, pest control, or aesthetic value. The growth in pet adoption is driven by an increasing focus on companionship and mental well-being, with more individuals seeking pets for emotional support and to reduce loneliness, particularly in urban settings. The animal therapeutics and diagnostics market supports this trend, as the expanding pet-owning population increases demand for medical treatments, health monitoring, and diagnostic services to ensure pets remain healthy and well cared for. For instance, in March 2025, according to the American Pet Products Association, a US-based non-profit association, 94 million U.S. households owned at least one pet, up from 82 million in 2023. Therefore, the rising pet adoption rate is driving the growth of the animal therapeutics and diagnostics market.

Leading players operating in the animal therapeutics and diagnostics market are focusing on innovations such as telemedicine platforms for pet healthcare to gain a competitive advantage. Telemedicine refers to the delivery of healthcare services through remote diagnosis, consultation, treatment, and monitoring using telecommunications technologies such as video conferencing, phone calls, or secure messaging platforms. For instance, in June 2023, Cargill Inc., a US-based food corporation, launched Zoonivet, a digital pet care application. This telehealth platform streamlines pet healthcare by connecting pet owners with qualified veterinarians through video consultations, making primary pet care more accessible and convenient. Zoonivet also plans to offer services such as surgery, home diagnostics, medication delivery, pet food, and pet boarding across major Indian markets.

In October 2023, Zomedica, a US-based veterinary health company, announced the acquisition of Qorvo Biotechnologies LLC (QBT) for an undisclosed amount. Through this acquisition, Zomedica aims to integrate Qorvo’s advanced diagnostic technologies into its existing product portfolio, including innovative biosensing and diagnostic platforms that enhance the accuracy and speed of veterinary testing. Qorvo Biotechnologies LLC (QBT) is a US-based company specializing in the development of point-of-care diagnostic solutions.

Major companies operating in the animal therapeutics and diagnostics market are Zoetis Inc., Boehringer Ingelheim Animal Health USA Inc., Virbac AH Inc., Ceva Animal Health Inc., Heska Corporation, IDEXX Laboratories Inc., Bayer Animal Health LLC, Merck & Co. Inc. Animal Health Division, Sanofi-Aventis Animal Health Inc., Elanco Animal Health Incorporated, IDvet, MSD Animal Health, Vetoquinol S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Kindred Biosciences Inc., Neogen Corporation, Abaxis Inc., Pfizer Animal Health, Norbrook Laboratories Limited, BioNote Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., bioMérieux Inc.

North America was the largest region in the animal therapeutics and diagnostics market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global animal therapeutics and diagnostics market report during the forecast period. The regions covered in the animal therapeutics and diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the animal therapeutics and diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the animal therapeutics and diagnostics market by increasing costs of imported diagnostic instruments, reagents, and pharmaceutical ingredients, affecting pricing and procurement cycles. Companion animal and livestock segments in regions such as North America and Europe are most impacted due to reliance on cross-border supply chains. However, tariffs have encouraged domestic manufacturing, local sourcing of inputs, and innovation in cost-efficient diagnostic and therapeutic solutions, supporting long-term market resilience.

The animal therapeutics and diagnostics market research report is one of a series of new reports that provides animal therapeutics and diagnostics market statistics, including animal therapeutics and diagnostics industry global market size, regional shares, competitors with a animal therapeutics and diagnostics market share, detailed animal therapeutics and diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the animal therapeutics and diagnostics industry. This animal therapeutics and diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Animal therapeutics involve the application of medical procedures to improve the health of animals, while animal diagnostics focus on identifying and analyzing illnesses that impact animals.

The primary animal types for animal therapeutics and diagnostics include companion animals, cattle, pigs, and poultry. Companion animals are defined as tame or domestic-bred animals that can readily fulfill their social needs as companions in homes or through close daily interaction with humans. The diverse range of products in this domain includes animal diagnostics products, instruments, consumables, and animal therapeutics products, such as anti-parasitic drugs, antibiotics, anti-inflammatory drugs, and anesthetics.

The animal therapeutics and diagnostics market include revenues earned by entities by providing services related to identifying and determining whether an animal has any viral, bacterial, parasitic, or other types of illnesses and related technologies such as clinical biochemistry, immunodiagnostics, molecular diagnostics, hematology, urinalysis, microbiology, and histopathology tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.